Skip to main content
. 2018 Feb 2;17:22. doi: 10.1186/s12944-018-0665-0

Table 3.

Identification of potential serum lipidomic biomarkers in migraine patients

No. Metabolites Ion adduct Retention time(min) Experimental Mass,M/z Fold change (Migraine/Control) p value
Acylcarnitine (positive ion)
1 Acylcarnitine15:3 [M]+ 2.22 380.2813 3.839↑ 0.005
2 Acylcarnitine 21:4 [M]+ 3.37 462.3571 3.520↑ 0.000
3 Acylcarnitine 11:1 [M]+ 1.95 328.248 2.094↑ 0.004
4 Acylcarnitine 14:3 [M]+ 2.01 366.2634 0.478↓ 0.007
5 Acylcarnitine 10:1 [M]+ 1.9 314.2327 0.465↓ 0.001
6 Acylcarnitine 24:0 [M]+ 9.93 512.4677 0.435↓ 0.009
7 Acylcarnitine 10:0 [M]+ 1.95 316.2485 0.402↓ 0.002
8 Acylcarnitine 26:0 [M]+ 12.49 540.498 0.377↓ 0.000
9 Acylcarnitine 20:0 [M]+ 6.09 456.4047 0.348↓ 0.000
Cer_NS (positive ion)
10 Cer_NS 34:1;
Cer_NS(d18:1/16:0)
[M + H]+ 14.75 538.5197 3.520↑ 0.000
11 Cer_NS 36:3;
Cer_NS(d18:2/18:1)
[M + H]+ 13.19 562.5194 2.723↑ 0.000
12 Cer_NS 36:2;
Cer_NS(d18:2/18:0)
[M + H]+ 14.86 564.5356 2.430↑ 0.000
lysoPC (positive ion)
13 lysoPC 20:0; PC(20:0/0:0) [M + H]+ 5.11 552.4031 2.860↑ 0.000
14 lysoPC 22:5; PC(22:5(4Z,7Z,10Z,13Z,16Z)/0:0) [M + H]+ 3.06 570.3521 0.474↓ 0.002
15 lysoPC 22:0; PC(22:0/0:0) [M + H]+ 8.07 580.4342 0.452↓ 0.012
16 lysoPC 18:2; PC(18:2(6Z,9Z)/0:0) [M + H]+ 3.09 520.3403 0.430↓ 0.019
17 lysoPC 15:0; PC(15:0/0:0) [M + H]+ 3.14 482.3243 0.423↓ 0.000
18 lysoPC 14:0; PC(14:0/0:0) [M + H]+ 2.89 468.309 0.393↓ 0.000
19 lysoPC 24:0; PC(24:0/0:0) [M + H]+ 10.33 608.475 0.337↓ 0.000
20 lysoPC 16:0; PC(16:0/0:0) [M + H]+ 5.22 496.3397 0.244↓ 0.001
lysoPE (positive ion)
21 lysoPE 18:2; PE(18:2(6Z,9Z)/0:0) [M + H]+ 3.23 478.2933 0.466↓ 0.015
22 lysoPE 18:1; PE(18:1(17Z)/0:0) [M + H]+ 3.98 480.3085 0.461↓ 0.023
23 lysoPE 22:5; PE(22:5(4Z,7Z,10Z,13Z,16Z)/0:0) [M + H]+ 3.05 528.2969 0.411↓ 0.007
24 lysoPE 24:0; PE(24:0/0:0) [M + H]+ 10.62 566.4199 0.349↓ 0.016
lysoPE (negative ion)
25 lysoPE 20:3; PE(20:3(5Z,8Z,11Z)/0:0) [M-H]- 3.73 502.2946 0.426↓ 0.014
lysoPE 18:1; PE(18:1(17Z)/0:0) [M-H]- 4.02 478.2952 0.401↓ 0.014
lysoPE 18:2; PE(18:2(6Z,9Z)/0:0) [M-H]- 3.26 476.2791 0.346↓ 0.007
lysoPE 22:5; PE(22:5(4Z,7Z,10Z,13Z,16Z)/0:0) [M-H]- 3.27 526.2956 0.388↓ 0.014
26 lysoPE 18:3; PE(18:3(6Z,9Z,12Z)/0:0) [M-H]- 2.89 474.2632 0.380↓ 0.002
27 lysoPE 22:6; PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) [M-H]- 3.12 524.2782 0.338↓ 0.003
28 lysoPE 20:4; PE(20:4(5Z,8Z,11Z,14Z)/0:0) [M-H]- 3.29 500.2796 0.332↓ 0.003
29 lysoPE 22:4; PE(22:4(7Z,10Z,13Z,16Z)/0:0) [M-H]- 3.9 528.311 0.309↓ 0.014